Cargando…

Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib

Introduction of targeted therapy in the treatment of metastatic cutaneous malignant melanoma (CMM) has improved clinical outcome during the last years. However, only in a subset of the CMM patients, this will lead to long-term effects. CEBPB is a transcription factor that has been implicated in vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidarsdottir, Linda, Fernandes, Rita Valador, Zachariadis, Vasilios, Das, Ishani, Edsbäcker, Elin, Sigvaldadottir, Ingibjorg, Azimi, Alireza, Höiom, Veronica, Hansson, Johan, Grandér, Dan, Egyházi Brage, Suzanne, Pokrovskaja Tamm, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles: Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469874/ https://www.ncbi.nlm.nih.gov/pubmed/32467529 http://dx.doi.org/10.1097/CMR.0000000000000675

Ejemplares similares

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
por: Vidarsdottir, Linda, et al.
Publicado: (2021)

Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
por: Li, Hailong, et al.
Publicado: (2022)

Prospective signs of cleidocranial dysplasia in Cebpb deficiency
por: Huang, Boyen, et al.
Publicado: (2014)

Changes in CEBPB expression in circulating leukocytes following eccentric elbow-flexion exercise
por: Blackwell, Jamie, et al.
Publicado: (2014)

Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling
por: Wang, Xiaoyang, et al.
Publicado: (2022)

Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
por: Das, Ishani, et al.
Publicado: (2019)

Loss of Stemness, EMT, and Supernumerary Tooth Formation in Cebpb(−/−)Runx2(+/−) Murine Incisors
por: Saito, Kazuyuki, et al.
Publicado: (2018)

Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents
por: Zhou, Qing, et al.
Publicado: (2021)

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
por: Yang, Jingrun, et al.
Publicado: (2022)

Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells
por: Du, Chenghua, et al.
Publicado: (2016)

Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2019)

Transcription factor CEBPB inhibits the proliferation of osteosarcoma by regulating downstream target gene CLEC5A
por: Lu, Jianhua, et al.
Publicado: (2019)

Deficiency of RARα Suppresses Decidualization via Downregulating CEBPB Transcription in Women With Recurrent Implantation Failure
por: Huang, Caiyi, et al.
Publicado: (2022)

CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis
por: Wang, Zhengrong, et al.
Publicado: (2022)

Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6
por: Ren, Yaoqiang, et al.
Publicado: (2023)

Transcription Factor CEBPB Inhibits the Expression of the Human HTR1A by Binding to 5′ Regulatory Region In Vitro
por: Liu, Yong-Ping, et al.
Publicado: (2019)

Corrigendum: Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2020)

DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter
por: Shao, Keke, et al.
Publicado: (2021)

Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation
por: Xu, Chengzhi, et al.
Publicado: (2022)

Cebpb Regulates Skeletal Stem Cell Osteogenic Differentiation and Fracture Healing via the WNT/β-Catenin Pathway
por: Wang, Jiansong, et al.
Publicado: (2022)

Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers
por: Greene, Lloyd A., et al.
Publicado: (2023)

CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response
por: Westin, Erik R, et al.
Publicado: (2023)

TET2 is recruited by CREB to promote Cebpb, Cebpa, and Pparg transcription by facilitating hydroxymethylation during adipocyte differentiation
por: Liu, Yunjia, et al.
Publicado: (2023)

CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo
por: Mann, Ishminder K., et al.
Publicado: (2013)

Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers
por: Jinesh, Goodwin G., et al.
Publicado: (2018)

PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway
por: Liu, Min, et al.
Publicado: (2022)

CEBPB/POU2F2 modulates endothelin 1 expression in prehypertensive SHR vascular smooth muscle cells
por: Yang, Tien-Chun, et al.
Publicado: (2023)

PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis
por: WANG, HAN, et al.
Publicado: (2022)

Investigation of the effects of urea cycle amino acids on the expression of ALB and CEBPB in the human hepatocellular carcinoma cell line FLC-4
por: Fujimi, Takahiko J., et al.
Publicado: (2020)

LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer
por: Yang, Shuyan, et al.
Publicado: (2021)

Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis
por: Zhou, Zili, et al.
Publicado: (2022)

Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids
por: Ye, Yongqin, et al.
Publicado: (2023)

G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells
por: Fu, Wanbin, et al.
Publicado: (2022)

Retracted: LINC00035 Transcriptional Regulation of SLC16A3 via CEBPB Affects Glycolysis and Cell Apoptosis in Ovarian Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling in d-galactose-induced aging mice
por: Zhou, Xiaohai, et al.
Publicado: (2023)

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
por: Azimi, Alireza, et al.
Publicado: (2017)

STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes
por: Edsbäcker, Elin, et al.
Publicado: (2019)

Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma
por: Costa Svedman, Fernanda, et al.
Publicado: (2022)

Association of LACC1, CEBPB-PTPN1, RIPK2 and ADO-EGR2 with ocular Behcet’s disease in a Chinese Han population
por: Wu, Pengcheng, et al.
Publicado: (2018)

PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation
por: Du, Qianqian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mqq5d283pasci1dbi40j63gmrg